Shanghai Shen Lian Biomedical Corporation Class ASSE: 688098

Announcement on Attending the 2025 Semi-annual SSE STAR Market Innovative Drug Industry Collective Performance Briefing

· Issued by Shanghai Shen Lian Biomedical Corporation Class A via Shanghai Stock Exchange
Announcement on Attending the 2025 Semi-annual SSE STAR Market Innovative Drug Industry Collective Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis